CONCENTRATIONS |
12 Months Ended |
---|---|
Dec. 31, 2020 | |
CONCENTRATIONS | |
NOTE L - CONCENTRATIONS |
Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2020 and 2019. Revenue from one licensee constituted an aggregate of 94% of the Company’s revenue for the year ended December 31, 2020. Revenue from two licensees constituted approximately 69% of the Company’s revenue for the year ended December 31, 2019. At December 31, 2020, there were no royalty receivables from licensees. At December 31, 2019, royalty receivables from four licensees constituted approximately 90% of the Company’s royalty receivables. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|